PB

Paul Biondi

General Partner and President of Pioneering Medicines

New York City Metropolitan Area

Investor
VC

Invests in

  • Min Investment:

    $500,000.00

  • Max Investment:

    $15,000,000.00

  • Target Investment:

    $7,000,000.00

Education

Lists including Paul

AM
AR
AG
AH

Based in NYC

2600 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

FP
Flagship Pioneering

2019

  • General Partner

    2024

  • Executive Partner

    2019 - 2024

PM
Pioneering Medicines

2019

  • President, Pioneering Medicines at Flagship Pioneering

    2019

BS
Bristol-Myers Squibb

2005 - 2019

  • Head of Business Development

    2015 - 2019

    Head of Business Development and Strategy for all of BMS.

  • Senior Vice President, R&D Operations

    2005 - 2015

Mercer Management Consulting

1993 - 2002

  • Principal

    1993 - 2002